These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 15128787)
1. Stimulation by soluble CD70 promotes strong primary and secondary CD8+ cytotoxic T cell responses in vivo. Rowley TF; Al-Shamkhani A J Immunol; 2004 May; 172(10):6039-46. PubMed ID: 15128787 [TBL] [Abstract][Full Text] [Related]
2. CD70 signaling is critical for CD28-independent CD8+ T cell-mediated alloimmune responses in vivo. Yamada A; Salama AD; Sho M; Najafian N; Ito T; Forman JP; Kewalramani R; Sandner S; Harada H; Clarkson MR; Mandelbrot DA; Sharpe AH; Oshima H; Yagita H; Chalasani G; Lakkis FG; Auchincloss H; Sayegh MH J Immunol; 2005 Feb; 174(3):1357-64. PubMed ID: 15661893 [TBL] [Abstract][Full Text] [Related]
3. The adjuvant effects of Mycobacterium tuberculosis heat shock protein 70 result from the rapid and prolonged activation of antigen-specific CD8+ T cells in vivo. Harmala LA; Ingulli EG; Curtsinger JM; Lucido MM; Schmidt CS; Weigel BJ; Blazar BR; Mescher MF; Pennell CA J Immunol; 2002 Nov; 169(10):5622-9. PubMed ID: 12421941 [TBL] [Abstract][Full Text] [Related]
4. Systemic administration of IL-15 augments the antigen-specific primary CD8+ T cell response following vaccination with peptide-pulsed dendritic cells. Rubinstein MP; Kadima AN; Salem ML; Nguyen CL; Gillanders WE; Cole DJ J Immunol; 2002 Nov; 169(9):4928-35. PubMed ID: 12391205 [TBL] [Abstract][Full Text] [Related]
5. Late signals from CD27 prevent Fas-dependent apoptosis of primary CD8+ T cells. Dolfi DV; Boesteanu AC; Petrovas C; Xia D; Butz EA; Katsikis PD J Immunol; 2008 Mar; 180(5):2912-21. PubMed ID: 18292513 [TBL] [Abstract][Full Text] [Related]
6. Cutting edge: a critical role for CD70 in CD8 T cell priming by CD40-licensed APCs. Taraban VY; Rowley TF; Al-Shamkhani A J Immunol; 2004 Dec; 173(11):6542-6. PubMed ID: 15557144 [TBL] [Abstract][Full Text] [Related]
7. Modulation by IL-2 of CD70 and CD27 expression on CD8+ T cells: importance for the therapeutic effectiveness of cell transfer immunotherapy. Huang J; Kerstann KW; Ahmadzadeh M; Li YF; El-Gamil M; Rosenberg SA; Robbins PF J Immunol; 2006 Jun; 176(12):7726-35. PubMed ID: 16751420 [TBL] [Abstract][Full Text] [Related]
8. The size and phenotype of virus-specific T cell populations is determined by repetitive antigenic stimulation and environmental cytokines. Gamadia LE; van Leeuwen EM; Remmerswaal EB; Yong SL; Surachno S; Wertheim-van Dillen PM; Ten Berge IJ; Van Lier RA J Immunol; 2004 May; 172(10):6107-14. PubMed ID: 15128796 [TBL] [Abstract][Full Text] [Related]
9. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy. Cannons JL; Lau P; Ghumman B; DeBenedette MA; Yagita H; Okumura K; Watts TH J Immunol; 2001 Aug; 167(3):1313-24. PubMed ID: 11466348 [TBL] [Abstract][Full Text] [Related]
10. The CD70/CD27 pathway is critical for stimulation of an effective cytotoxic T cell response against B cell precursor acute lymphoblastic leukemia. Glouchkova L; Ackermann B; Zibert A; Meisel R; Siepermann M; Janka-Schaub GE; Goebel U; Troeger A; Dilloo D J Immunol; 2009 Jan; 182(1):718-25. PubMed ID: 19109206 [TBL] [Abstract][Full Text] [Related]
11. During viral infection of the respiratory tract, CD27, 4-1BB, and OX40 collectively determine formation of CD8+ memory T cells and their capacity for secondary expansion. Hendriks J; Xiao Y; Rossen JW; van der Sluijs KF; Sugamura K; Ishii N; Borst J J Immunol; 2005 Aug; 175(3):1665-76. PubMed ID: 16034107 [TBL] [Abstract][Full Text] [Related]
12. CD70 deficiency impairs effector CD8 T cell generation and viral clearance but is dispensable for the recall response to lymphocytic choriomeningitis virus. Munitic I; Kuka M; Allam A; Scoville JP; Ashwell JD J Immunol; 2013 Feb; 190(3):1169-79. PubMed ID: 23269247 [TBL] [Abstract][Full Text] [Related]
13. CD134L engagement enhances human B cell Ig production: CD154/CD40, CD70/CD27, and CD134/CD134L interactions coordinately regulate T cell-dependent B cell responses. Morimoto S; Kanno Y; Tanaka Y; Tokano Y; Hashimoto H; Jacquot S; Morimoto C; Schlossman SF; Yagita H; Okumura K; Kobata T J Immunol; 2000 Apr; 164(8):4097-104. PubMed ID: 10754303 [TBL] [Abstract][Full Text] [Related]
14. Induction of CD70 on dendritic cells through CD40 or TLR stimulation contributes to the development of CD8+ T cell responses in the absence of CD4+ T cells. Bullock TN; Yagita H J Immunol; 2005 Jan; 174(2):710-7. PubMed ID: 15634890 [TBL] [Abstract][Full Text] [Related]
15. CD27-mediated activation of murine NK cells. Takeda K; Oshima H; Hayakawa Y; Akiba H; Atsuta M; Kobata T; Kobayashi K; Ito M; Yagita H; Okumura K J Immunol; 2000 Feb; 164(4):1741-5. PubMed ID: 10657619 [TBL] [Abstract][Full Text] [Related]
16. CD27 costimulation contributes substantially to the expansion of functional memory CD8(+) T cells after peptide immunization. Taraban VY; Rowley TF; Kerr JP; Willoughby JE; Johnson PM; Al-Shamkhani A; Buchan SL Eur J Immunol; 2013 Dec; 43(12):3314-23. PubMed ID: 24002868 [TBL] [Abstract][Full Text] [Related]
17. In vivo cross-presentation of a soluble protein antigen: kinetics, distribution, and generation of effector CTL recognizing dominant and subdominant epitopes. Nelson D; Bundell C; Robinson B J Immunol; 2000 Dec; 165(11):6123-32. PubMed ID: 11086045 [TBL] [Abstract][Full Text] [Related]
18. CD8 T cell priming in the presence of IFN-α renders CTLs with improved responsiveness to homeostatic cytokines and recall antigens: important traits for adoptive T cell therapy. Hervas-Stubbs S; Mancheño U; Riezu-Boj JI; Larraga A; Ochoa MC; Alignani D; Alfaro C; Morales-Kastresana A; Gonzalez I; Larrea E; Pircher H; Le Bon A; Lopez-Picazo JM; Martín-Algarra S; Prieto J; Melero I J Immunol; 2012 Oct; 189(7):3299-310. PubMed ID: 22925929 [TBL] [Abstract][Full Text] [Related]
19. In vivo impact of CpG1826 oligodeoxynucleotide on CD8 T cell primary responses and survival. Beloeil L; Tomkowiak M; Angelov G; Walzer T; Dubois P; Marvel J J Immunol; 2003 Sep; 171(6):2995-3002. PubMed ID: 12960324 [TBL] [Abstract][Full Text] [Related]
20. A soluble lymphocyte activation gene-3 molecule used as a vaccine adjuvant elicits greater humoral and cellular immune responses to both particulate and soluble antigens. El Mir S; Triebel F J Immunol; 2000 Jun; 164(11):5583-9. PubMed ID: 10820232 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]